Drugs / DpC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02688101 | Apr 2016 → Oct 2017 | neoplasm | Collaborative Medicinal Development Pty Limited | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DpC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02688101 ↗ |
| Route | Oral | “DpC capsules, administered orally” NCT02688101 ↗ |